Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-012089-30Phase 4Completed
Phase 4, open-label, single-arm trial of somatropin in growth disorder and insulin-like growth factor 1 deficiency, sponsored by UZ Brussel. Primary endpoint: Discordant IGF generation test frequency. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-012089-30.